phenylalanine and Sleepiness

phenylalanine has been researched along with Sleepiness in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (50.00)24.3611
2020's3 (50.00)2.80

Authors

AuthorsStudies
Ahmed, M; Baladi, M; Chandler, P; Foldvary-Schaefer, N; Hedner, J; Lee, L; Malhotra, A; Mayer, G; Pepin, JL; Sarmiento, K; Schwab, R; Shapiro, C; Strollo, PJ1
Garland, S; Piszczatoski, C; Powell, J1
Chen, G; Gao, H; Li, X; Wang, J; Wang, T; Xu, X; Xu, Z; Yang, S1
Black, J; Carter, LP; Chen, D; Collop, N; Hedner, J; Lee, L; Lorch, DG; Lu, Y; Pépin, JL; Redline, S; Strollo, PJ1
Black, J; Carter, LP; Chen, D; Corser, BC; Dauvilliers, Y; Emsellem, H; Lu, Y; Mayer, G; Plazzi, G; Shapiro, C; Thorpy, MJ; Wang, H1

Reviews

3 review(s) available for phenylalanine and Sleepiness

ArticleYear
Solriamfetol (Sunosi) for excessive daytime sleepiness.
    The Medical letter on drugs and therapeutics, 2019, Aug-26, Volume: 61, Issue:1579

    Topics: Adrenergic Uptake Inhibitors; Carbamates; Dopamine Uptake Inhibitors; Humans; Phenylalanine; Randomized Controlled Trials as Topic; Sleepiness

2019
Solriamfetol for Excessive Sleepiness in Narcolepsy and Obstructive Sleep Apnea.
    The Annals of pharmacotherapy, 2020, Volume: 54, Issue:10

    Topics: Carbamates; Clinical Trials as Topic; Disorders of Excessive Somnolence; Humans; Narcolepsy; Phenylalanine; Sleep Apnea, Obstructive; Sleepiness; Treatment Outcome; United States; United States Food and Drug Administration; Wakefulness-Promoting Agents

2020
Efficacy and safety of solriamfetol for excessive sleepiness in narcolepsy and obstructive sleep apnea: findings from randomized controlled trials.
    Sleep medicine, 2021, Volume: 79

    Topics: Adult; Carbamates; Disorders of Excessive Somnolence; Humans; Narcolepsy; Phenylalanine; Randomized Controlled Trials as Topic; Sleep Apnea, Obstructive; Sleepiness

2021

Trials

3 trial(s) available for phenylalanine and Sleepiness

ArticleYear
Long-term study of the safety and maintenance of efficacy of solriamfetol (JZP-110) in the treatment of excessive sleepiness in participants with narcolepsy or obstructive sleep apnea.
    Sleep, 2020, 02-13, Volume: 43, Issue:2

    Topics: Carbamates; Disorders of Excessive Somnolence; Double-Blind Method; Humans; Narcolepsy; Phenylalanine; Sleep Apnea, Obstructive; Sleepiness; Treatment Outcome

2020
Solriamfetol for the Treatment of Excessive Sleepiness in OSA: A Placebo-Controlled Randomized Withdrawal Study.
    Chest, 2019, Volume: 155, Issue:2

    Topics: Adult; Aged; Carbamates; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Phenylalanine; Sleep Apnea, Obstructive; Sleepiness; Treatment Outcome; Wakefulness

2019
A randomized study of solriamfetol for excessive sleepiness in narcolepsy.
    Annals of neurology, 2019, Volume: 85, Issue:3

    Topics: Adult; Carbamates; Double-Blind Method; Female; Humans; Male; Middle Aged; Narcolepsy; Phenylalanine; Sleep Latency; Sleepiness; Treatment Outcome; Wakefulness-Promoting Agents; Young Adult

2019